Hillhouse, Mitsui vying for Singapore's Eu Yan Sang in $700m deal

Hillhouse and Japan’s Mitsui & Co have emerged as final bidders vying for Singapore-headquartered traditional Chinese medicine chain Eu Yan Sang International, in a deal that could fetch over $700 million, two people with knowledge of the matter said.